Truist Financial Forecasts Strong Price Appreciation for RadNet (NASDAQ:RDNT) Stock
RadNet (NASDAQ:RDNT – Free Report) had its target price hoisted by Truist Financial from $80.00 to $94.00 in a research note ...
RadNet股票获得买入评级，盈利超预期后目标价上调
鉴于最近的发展，Truist Securities已经修订了RadNet 2024年至2026年的调整后EBITDA估计。新的估计为2024年$280.4百万，高于先前的$274.0百万估计。2025年和2026年的估计分别上调至$308.0百万和$336.0百万，高于先前的$300.0百万和$325.0百万预测。
Nasdaq2 天
Analyst Scoreboard: 4 Ratings For RadNet
4 analysts have expressed a variety of opinions on RadNet (NASDAQ:RDNT) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of ...
Investing3 天
RadNet stock receives Buy rating, with price target increased following earnings beat
The raised price target and maintained Buy rating reflect a positive outlook on RadNet (NASDAQ:RDNT)'s financial health and growth potential, particularly in the wake of its third-quarter ...
Investing2 天
RadNet stock receives Buy rating, with price target increased following earnings beat
The raised price target and maintained Buy rating reflect a positive outlook on RadNet (NASDAQ:RDNT)'s financial health and growth potential, particularly in the wake of its third-quarter performance ...
RadNet’s Wholly-Owned Subsidiary, DeepHealth, to Use CARPL.ai's Platform to Develop a New ...
DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation to ensure AI scalability, performance ...
Taiwan News2 天
CORRECTION: RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer detection. The clearance enables RadNet’s DeepHealth and GE HealthCare ...
Morningstar3 天
CORRECTION: RadNet’s DeepHealth Subsidiary Expands FDA Clearance for SmartMammo™ Solution
The clearance enables RadNet’s DeepHealth and GE HealthCare collaboration to bring together the SmartMammo and Senographe Pristina solutions and transform breast cancer diagnosis. SOMERVILLE ...
Stockhouse2 天
RadNet's DeepHealth Subsidiary Expands FDA Clearance for SmartMammo(TM) Solution
The clearance enables RadNet’s DeepHealth and GE HealthCare collaboration to bring together the SmartMammo and Senographe Pristina solutions and transform breast cancer diagnosis.
Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous ...
Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet ...
RadNet’s DeepHealth expands FDA clearance for SmartMammo solution
DeepHealth, a wholly-owned subsidiary of RadNet (RDNT), has received expanded FDA 510(k) clearance for its mammography software. SmartMammo Dx, ...
RadNet第三季度业绩创纪录,扩张势头强劲
RadNet, Inc. (NASDAQ: RDNT) 在2024年第三季度交出了创纪录的财务业绩,同比收入大幅增长14.7%,达到4.611亿美元。公司调整后的EBITDA也显著增长27.2%,达到7370万美元。尽管运营数据强劲,RadNet的净利润有所下降,报告期内为320万美元,低于去年同期的1750万美元。